News | May 16, 2021
Cadila Healthcare divests animal health business: ICICI Securities
The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.
The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.
The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,
Seasoned pharma leader recognized for driving sales excellence, marketing strategy, and business growth
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
Dr. Lall brings extensive experience in healthcare operations, business strategy, and hospital management
Veteran healthcare leader to oversee operations across Tamil Nadu and Kerala, driving growth and operational excellence
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
First immunotherapy combination approved in the US for BCG-naïve high-risk NMIBC demonstrates a 32% reduction in the risk of disease recurrence, progression, or death
The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments
Subscribe To Our Newsletter & Stay Updated
